Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma

Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma

<p>Simvastatin responsive genes</p>

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkki:	Gia-Buu Tran (16437051) (author)
Eará dahkkit:	Jane Ding (16437054) (author), Bingwei Ye (16437057) (author), Mengling Liu (16437060) (author), Yajie Yu (16437063) (author), Yunhong Zha (16437066) (author), Zheng Dong (16437069) (author), Kebin Liu (14939874) (author), Sunil Sudarshan (16437072) (author), Han-Fei Ding (16437075) (author)
Almmustuhtton:	2025
Fáttát:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Drug Targets Metabolism Metabolic pathways Pediatric Cancers Small Molecule Agents
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid

Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Dahkki: Gia-Buu Tran (16437051)
Almmustuhtton: (2025)

Table S4 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Dahkki: Gia-Buu Tran (16437051)
Almmustuhtton: (2025)

Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Dahkki: Gia-Buu Tran (16437051)
Almmustuhtton: (2025)

Supplementary Table S1 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Dahkki: Gia-Buu Tran (16437051)
Almmustuhtton: (2025)

Supplemental Table 1 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
Dahkki: Haowen Jiang (14963613)
Almmustuhtton: (2025)

Supplemental Table 2 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
Dahkki: Haowen Jiang (14963613)
Almmustuhtton: (2025)

Supplemental Table 3 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
Dahkki: Haowen Jiang (14963613)
Almmustuhtton: (2025)

Supplemental Table 4 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
Dahkki: Haowen Jiang (14963613)
Almmustuhtton: (2025)

Table S1 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8<sup>+</sup> T Cells
Dahkki: Snehanshu Chowdhury (14957031)
Almmustuhtton: (2025)

Supplementary Table S2 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
Dahkki: Pochung Jordan Chou (14851578)
Almmustuhtton: (2025)

Supplementary Table S3 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
Dahkki: Pochung Jordan Chou (14851578)
Almmustuhtton: (2025)

Supplementary Table S4 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
Dahkki: Pochung Jordan Chou (14851578)
Almmustuhtton: (2025)

Supplementary Table 1 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
Dahkki: David Olayinka Kamson (16617218)
Almmustuhtton: (2025)

Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
Dahkki: David Olayinka Kamson (16617218)
Almmustuhtton: (2025)

Effects of <i>T. gondii</i> infection on rat gut microbiota diversity.
Dahkki: Ji-Xin Zhao (22056386)
Almmustuhtton: (2025)

Supplementary Data File 1 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
Dahkki: William Kelly (15439117)
Almmustuhtton: (2025)

Supplementary Data File 2 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
Dahkki: William Kelly (15439117)
Almmustuhtton: (2025)

Table S1 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Dahkki: Thomas Farge (15112135)
Almmustuhtton: (2025)

Table S2 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Dahkki: Thomas Farge (15112135)
Almmustuhtton: (2025)

Table S3 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Dahkki: Thomas Farge (15112135)
Almmustuhtton: (2025)

Table S4 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Dahkki: Thomas Farge (15112135)
Almmustuhtton: (2025)

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Dahkki: Evangeline R. Jackson (15558808)
Almmustuhtton: (2025)

Figure S1 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Dahkki: Sebastian Johannes Schober (14971891)
Almmustuhtton: (2025)

Figure S2 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Dahkki: Sebastian Johannes Schober (14971891)
Almmustuhtton: (2025)

Figure S3 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Dahkki: Sebastian Johannes Schober (14971891)
Almmustuhtton: (2025)

Figure S4 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Dahkki: Sebastian Johannes Schober (14971891)
Almmustuhtton: (2025)

Figure S5 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Dahkki: Sebastian Johannes Schober (14971891)
Almmustuhtton: (2025)

Supplementary Table 1 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Dahkki: Chun-Miao Deng (15618965)
Almmustuhtton: (2025)

Supplementary Table 2 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Dahkki: Chun-Miao Deng (15618965)
Almmustuhtton: (2025)

Supplementary Table 3 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Dahkki: Chun-Miao Deng (15618965)
Almmustuhtton: (2025)

Supplementary Table 4 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Dahkki: Chun-Miao Deng (15618965)
Almmustuhtton: (2025)

Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Dahkki: Chun-Miao Deng (15618965)
Almmustuhtton: (2025)

Supplementary Table 7 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Dahkki: Chun-Miao Deng (15618965)
Almmustuhtton: (2025)

Supplementary Table 8 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Dahkki: Chun-Miao Deng (15618965)
Almmustuhtton: (2025)

Supplementary Table 9 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Dahkki: Chun-Miao Deng (15618965)
Almmustuhtton: (2025)

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
Dahkki: Gwo Yaw Ho (14961416)
Almmustuhtton: (2025)

Supplementary Video from Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma
Dahkki: Laura Privitera (16015972)
Almmustuhtton: (2025)

Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Dahkki: Elizabeth R. Tucker (15053624)
Almmustuhtton: (2025)

Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Dahkki: Elizabeth R. Tucker (15053624)
Almmustuhtton: (2025)

Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Dahkki: Elizabeth R. Tucker (15053624)
Almmustuhtton: (2025)

Cannot write session to /tmp/vufind_sessions/sess_pq2m7ca8f8rvqp6e4lirrs8fr6